Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Hu B, Zou T, Qin W, Shen X, et al. Inhibition of EGFR overcomes acquired lenvatinib resistance driven by STAT3-ABCB1 signaling in hepatocellular carcinoma. Cancer Res 2022 Sep 6. pii: 708982. doi: 10.1158/0008-5472.CAN-21-4140.
PMID: 36066408


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016